Trial Profile
Decitabine together with Aclacinomycin/Cytarabine to induce remission in patients with refractory acute myeloid leukemia
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2012
Price :
$35
*
At a glance
- Drugs Aclarubicin (Primary) ; Cytarabine (Primary) ; Decitabine (Primary)
- Indications Myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Planned End Date 29 Feb 2012 added as reported by Chinese Clinical Trial Register record.
- 21 Mar 2012 New trial record